Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
75.59 EUR | +1.67% |
|
+0.31% | +7.07% |
24/06 | DuPont's water unit draws interest from potential buyers, Bloomberg News reports | RE |
13/06 | DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.91 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 3.2 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.07% | 33.9B | - | ||
+3.85% | 74.91B | B | ||
-5.37% | 44.2B | A- | ||
+15.34% | 18.94B | B | ||
+12.06% | 11.84B | A- | ||
-21.12% | 10.17B | B | ||
-5.69% | 10.04B | - | ||
-3.25% | 8.59B | C- | ||
-0.72% | 8.82B | A- | ||
+2.50% | 7.75B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DD Stock
- 6D81 Stock
- Ratings DuPont de Nemours, Inc.